CKD-11101 Phase 3 IV Study in Patients Who Had Renal Anemia Receiving Hemodialysis

Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Participants With Chronic Kidney Disease

NCT04059913 ·Status: COMPLETED ·Phase: PHASE4

Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis

NCT07119372 ·Status: RECRUITING ·Phase: PHASE3

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg

NCT05245084 ·Status: COMPLETED ·Phase: PHASE1

A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease

NCT05951192 ·Status: COMPLETED ·Phase: PHASE4

Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers

NCT04952506 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Study of SAL-0951 in the Treatment of Renal Anemia in Patients Receiving Peritoneal Dialysis

NCT06720233 ·Status: COMPLETED ·Phase: PHASE3

A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.

NCT01146574 ·Status: COMPLETED ·Phase: PHASE2

Clinical Validation Study for Optimization of Anemia MAnagement in Hemodialysis Patients With End Stage Kidney Disease Using the Dialysis Anemia TReatmenT Model

NCT05936021 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis

NCT01750190 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetic/Pharmacodynamic Parameters of NNG-DEPO (Stimus) With Aranesp® (Amgen) in Treatment of Anemia in CKD Patients on Dialysis

NCT05636891 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Efficacy and Safety of QLG1218(Daprodustat) in Chinese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)

NCT07300111 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

PRevention of End Stage Kidney Disease by Darbepoetin Alfa In Chronic Kidney Disease Patients With nondiabeTic Kidney Disease

NCT01581073 ·Status: COMPLETED ·Phase: PHASE3

Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney Disease

NCT00806481 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of DDO-3055 in Healthy Volunteers and Patients With Chronic Kidney Disease

NCT03976115 ·Status: COMPLETED ·Phase: PHASE1

A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis

NCT05265325 ·Status: COMPLETED ·Phase: PHASE2

Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis

NCT01736150 ·Status: COMPLETED ·Phase: PHASE3

A Phase 2 Study of Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidney Disease on Hemodialysis

NCT01999582 ·Status: COMPLETED ·Phase: PHASE2

A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients

NCT05035641 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348

NCT05549401 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD)

NCT03242967 ·Status: WITHDRAWN ·Phase: PHASE3

Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers

NCT05089279 ·Status: COMPLETED ·Phase: PHASE1

Peginesatide for Anemia in Chronic Hemodialysis Patients

NCT00228449 ·Status: COMPLETED ·Phase: PHASE2

SAL-0951 Tablets in the Treatment of Renal Anemia in Non-dialysis Chronic Kidney Disease

NCT06016036 ·Status: COMPLETED ·Phase: PHASE3

Fixed Dose NESP Study in Subjects With CRI

NCT00526929 ·Status: COMPLETED ·Phase: PHASE2

Study of FG-4592 in Subjects With Chronic Kidney Disease in China

NCT01599507 ·Status: COMPLETED ·Phase: PHASE2